PCSK9: A link between air pollution and cardiovascular disease?

Abstract

Get full access to this article

View all access options for this article.

References

Brook

Rajagopalan

Pope

III et al.

Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010; 121: 2331–2378.

Rajagopalan

Al-Kindi

Brook

. Air pollution and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72: 2054–2070.

Munzel

Schmidt

Gori

. Environmental hazards, air pollution, and noise as novel cardiovascular risk factors. Eur Heart J 2015; 36: 1777–1779.

Peters

von Klot

Mittleman

et al.

Triggering of acute myocardial infarction by different means of transportation. Eur J Prev Cardiol 2013; 20: 750–758.

Newby

Mannucci

Tell

et al.

Expert position paper on air pollution and cardiovascular disease. Eur Heart J 2015; 36: 83b–93b.

Yang

Zhang

Thijs

et al.

Left ventricular function in relation to chronic residential air pollution in a general population. Eur J Prev Cardiol 2017; 24: 1416–1428.

Akintoye

Shi

Obaitan

et al.

Association between fine particulate matter exposure and subclinical atherosclerosis: a meta-analysis. Eur J Prev Cardiol 2016; 23: 602–612.

O’Neill

Veves

Zanobetti

et al.

Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 2005; 111: 2913–2920.

Macchi

Ferri

Favero

et al.

Long-term exposure to air pollution raises circulating levels of PCSK9 in obese individuals. Eur J Prev Cardiol 2019; 26: 578–588.

10.

Tibolla

Norata

Artali

et al.

Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis 2011; 21: 835–843.

11.

Laugsand

Asvold

Vatten

et al.

Circulating PCSK9 and risk of myocardial infarction: the HUNT Study in Norway. JACC Basic Transl Sci 2016; 1: 568–575.

12.

Leander

Malarstig

Van’t Hooft

et al.

Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation 2016; 133: 1230–1239.

13.

Ridker

Rifai

Bradwin

et al.

Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. Eur Heart J 2016; 37: 554–560.

14.

Munzel

Gori

Al-Kindi

et al.

Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J 2018; 39: 3543–3550.

15.

Walley

Thain

Russell

et al.

PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Transl Med 2014; 6: 258ra143–258ra143.

16.

Munzel

Sorensen

Gori

et al.

Environmental stressors and cardio-metabolic disease: part I – epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies. Eur Heart J 2017; 38: 550–556.

17.

Munzel

Sorensen

Gori

et al.

Environmental stressors and cardio-metabolic disease: part II – mechanistic insights. Eur Heart J 2017; 38: 557–564.